FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $11,919,000 | +23.5% | 112,256 | +1.2% | 0.22% | +22.0% |
| Q1 2014 | $9,650,000 | +101.5% | 110,921 | -2.7% | 0.18% | +106.8% |
| Q4 2013 | $4,789,000 | +13.1% | 113,993 | +18.4% | 0.09% | +7.3% |
| Q3 2013 | $4,234,000 | -5.3% | 96,245 | -26.7% | 0.08% | -9.9% |
| Q2 2013 | $4,473,000 | – | 131,279 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Magnetar Financial LLC | 950,000 | $100,871,000 | 1.68% |
| Camber Capital Management LP | 200,000 | $21,236,000 | 1.39% |
| OXFORD ASSET MANAGEMENT LLP | 378,901 | $40,080,000 | 1.30% |
| Magnetar Financial LLC | 734,006 | $77,937,000 | 1.30% |
| HARVEST MANAGEMENT LLC | 10,077 | $1,070,000 | 1.08% |
| FRANKLIN STREET ADVISORS INC /NC | 48,755 | $5,177,000 | 0.99% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 251,319 | $26,685,000 | 0.78% |
| Biondo Investment Advisors, LLC | 19,385 | $2,058,000 | 0.65% |
| Andromeda Capital LLC | 75,100 | $7,974,000 | 0.56% |
| CSS LLC/IL | 126,200 | $13,399,000 | 0.56% |